The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

(Reuters) - The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...

This activation may help improve insulin sensitivity, reduce sugar production in ... intrigued by its novel approach to boosting metabolic health using a liposomal delivery system. This method ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

New U.S. patent covers the design and composition of the BVP -- Positive results from ongoing preclinical studies support the potential of the ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Eversense 365 is said to be the world's first one-year CGM system, offering a new long-term solution for diabetes management.